A phase 2 trial of PNT2258 in solid tumors

Trial Profile

A phase 2 trial of PNT2258 in solid tumors

Phase of Trial: Phase II

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Rosomidnar (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jan 2017 According to a Sierra Oncology media release, this trial was originally conducted by ProNAi Therapeutics, Inc. but later on this company's name changed to Sierra Oncology.
    • 25 Aug 2015 New trial record
    • 21 Aug 2015 According to ProNAi therapeutics media release, company is planning to initiate this trial in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top